casinoslots| Jianshi Technology-B rose nearly 24% in late trading. The global commercialization of core product LuX-Valve continues to advance
Jianshi Technology-B (09877) rose 23% in late tradingcasinoslots.82%, currently quoted at HK$4.47, with a turnover of HK$53.86287 million.
In 2023, the company will continue to promote the clinical and commercialization of its core product LuX-Valve series products globally, as well as promote itscasinoslotsHe is researching clinical research and development of product pipelines, enriching product categories, and plans to comprehensively promote the commercialization of products after approval in 2024.
Zhongtai Securities previously pointed out that LuX-Valve is expected to be the first tricuspid valve replacement product in China and the second tricuspid valve replacement product in the world, with strong product power.
